{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:09:57Z","timestamp":1768277397907,"version":"3.49.0"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":221,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K08NS114172-01A1"],"award-info":[{"award-number":["1K08NS114172-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioblastoma (GBM) is the most common and aggressive primary adult brain tumor, with an estimated annual incidence of 17 000 new cases in the United States. Current treatments for GBM include chemotherapy, surgical resection, radiation therapy, and antiangiogenic therapy. However, despite the various therapeutic options, the 5-year survival rate remains at a dismal 5%. Temozolomide (TMZ) is the first-line chemotherapy drug for GBM; however, poor TMZ response is one of the main contributors to the dismal prognosis. Long non-coding RNAs (lncRNAs) are nonprotein coding transcripts greater than 200 nucleotides that have been implicated to mediate various GBM pathologies, including chemoresistance. In this review, we aim to frame the TMZ response in GBM via exploration of the lncRNAs mediating three major mechanisms of TMZ resistance: (1) regulation of the DNA damage response, (2) maintenance of glioma stem cell identity, and (3) exploitation of hypoxia-associated responses.<\/jats:p>","DOI":"10.1093\/noajnl\/vdac119","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T23:41:29Z","timestamp":1660174889000},"source":"Crossref","is-referenced-by-count":5,"title":["Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes"],"prefix":"10.1093","volume":"4","author":[{"given":"Edith","family":"Yuan","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristie","family":"Liu","sequence":"additional","affiliation":[{"name":"Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Tsung","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Attenello","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Keck School of Medicine, University of Southern California , Los Angeles, CA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"17","key":"2022091213240855700_CIT0001","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA."},{"issue":"5 suppl","key":"2022091213240855700_CIT0002","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1188\/16.CJON.S1.2-8","article-title":"Glioblastoma: overview of disease and treatment","volume":"20","author":"Davis","year":"2016","journal-title":"Clin J Oncol Nurs."},{"issue":"3","key":"2022091213240855700_CIT0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"issue":"10","key":"2022091213240855700_CIT0004","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"10","key":"2022091213240855700_CIT0005","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med."},{"issue":"7412","key":"2022091213240855700_CIT0006","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"issue":"23","key":"2022091213240855700_CIT0007","first-page":"5375","article-title":"Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea","volume":"56","author":"Liu","year":"1996","journal-title":"Cancer Res."},{"key":"2022091213240855700_CIT0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fonc.2018.00249","article-title":"Hypoxia-inducible factor-1\u03b1 activity as a switch for glioblastoma responsiveness to temozolomide","volume":"8","author":"Lo Dico","year":"2018","journal-title":"Front Oncol."},{"key":"2022091213240855700_CIT0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2013.06.001","article-title":"Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases","volume":"97","author":"Wu","year":"2013","journal-title":"Brain Res Bull."},{"issue":"1","key":"2022091213240855700_CIT0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12943-018-0812-2","article-title":"New insights into long noncoding RNAs and their roles in glioma","volume":"17","author":"Peng","year":"2018","journal-title":"Mol Cancer."},{"key":"2022091213240855700_CIT0011","doi-asserted-by":"crossref","first-page":"13616","DOI":"10.1038\/ncomms13616","article-title":"Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment","volume":"7","author":"Katsushima","year":"2016","journal-title":"Nat Commun."},{"key":"2022091213240855700_CIT0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.gene.2017.02.006","article-title":"Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway","volume":"610","author":"Hu","year":"2017","journal-title":"Gene."},{"issue":"1\u20132","key":"2022091213240855700_CIT0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-020-03712-y","article-title":"LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424","volume":"468","author":"Sun","year":"2020","journal-title":"Mol Cell Biochem."},{"key":"2022091213240855700_CIT0014","doi-asserted-by":"crossref","first-page":"670917","DOI":"10.3389\/fonc.2021.670917","article-title":"Role of long non-coding RNAs in conferring resistance in tumors of the nervous system","volume":"11","author":"Ghafouri-Fard","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"2022091213240855700_CIT0015","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41467-019-10025-2","article-title":"Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p","volume":"10","author":"Wu","year":"2019","journal-title":"Nat Commun."},{"issue":"6","key":"2022091213240855700_CIT0016","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4196\/kjpp.2019.23.6.475","article-title":"FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O6-methylguanine-DNA methyltransferase-dependent manner","volume":"23","author":"Shangguan","year":"2019","journal-title":"Korean J Physiol Pharmacol."},{"issue":"22","key":"2022091213240855700_CIT0017","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.18632\/aging.102455","article-title":"Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p\/CPEB4 axis","volume":"11","author":"Gu","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"2022091213240855700_CIT0018","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2022.02.016","article-title":"LncRNA UCA1\/miR-182-5p\/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways","volume":"123","author":"Cheng","year":"2022","journal-title":"Hum Pathol."},{"issue":"5","key":"2022091213240855700_CIT0019","doi-asserted-by":"crossref","first-page":"BSR20170696","DOI":"10.1042\/BSR20170696","article-title":"LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway","volume":"37","author":"Du","year":"2017","journal-title":"Biosci Rep."},{"issue":"1","key":"2022091213240855700_CIT0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13046-019-1139-6","article-title":"Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma","volume":"38","author":"Zhang","year":"2019","journal-title":"J Exp Clin Cancer Res."},{"issue":"3","key":"2022091213240855700_CIT0021","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41419-019-1477-5","article-title":"The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells","volume":"10","author":"Mazor","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"2022091213240855700_CIT0022","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41419-020-2540-y","article-title":"LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"2022091213240855700_CIT0023","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20201111","article-title":"LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p\/MAP3K1 axis","volume":"40","author":"Bi","year":"2020","journal-title":"Biosci Rep."},{"key":"2022091213240855700_CIT0024","doi-asserted-by":"crossref","first-page":"620883","DOI":"10.3389\/fcell.2021.620883","article-title":"Temozolomide treatment induces HMGB1 to promote the formation of glioma stem cells via the TLR2\/NEAT1\/Wnt pathway in glioblastoma","volume":"9","author":"Gao","year":"2021","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"2022091213240855700_CIT0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13577-019-00281-1","article-title":"LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p\/SOX9 axis","volume":"33","author":"Li","year":"2020","journal-title":"Hum Cell."},{"issue":"8","key":"2022091213240855700_CIT0026","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/cells9081859","article-title":"Targeting BC200\/miR218-5p signaling axis for overcoming temozolomide resistance and suppressing glioma stemness","volume":"9","author":"Su","year":"2020","journal-title":"Cells"},{"issue":"3","key":"2022091213240855700_CIT0027","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1159\/000478917","article-title":"Long non-coding RNA MALAT1 decreases the sensitivity of resistant glioblastoma cell lines to temozolomide","volume":"42","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem."},{"issue":"4","key":"2022091213240855700_CIT0028","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cam4.1384","article-title":"Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma","volume":"7","author":"Cai","year":"2018","journal-title":"Cancer Med"},{"issue":"14","key":"2022091213240855700_CIT0029","doi-asserted-by":"crossref","first-page":"22783","DOI":"10.18632\/oncotarget.15199","article-title":"MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"28","key":"2022091213240855700_CIT0030","doi-asserted-by":"crossref","first-page":"43835","DOI":"10.18632\/oncotarget.9699","article-title":"Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget."},{"key":"2022091213240855700_CIT0031","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/OTT.S154339","article-title":"The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt\/\u03b2-Catenin pathway","volume":"11","author":"Jia","year":"2018","journal-title":"Onco Targets Ther."},{"key":"2022091213240855700_CIT0032","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.2147\/OTT.S173244","article-title":"H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-\u03baB signaling","volume":"11","author":"Duan","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"10","key":"2022091213240855700_CIT0033","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1111\/jcmm.15233","article-title":"HOTAIR\/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma","volume":"24","author":"Zhang","year":"2020","journal-title":"J Cell Mol Med."},{"issue":"4","key":"2022091213240855700_CIT0034","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41419-022-04699-8","article-title":"Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"2022091213240855700_CIT0035","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/s41419-018-1183-8","article-title":"Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195\/TFPI-2 signaling modulation in glioblastoma","volume":"9","author":"Xu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"7","key":"2022091213240855700_CIT0036","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/jcb.25910","article-title":"LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway","volume":"118","author":"Liao","year":"2017","journal-title":"J Cell Biochem."},{"issue":"4","key":"2022091213240855700_CIT0037","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00280-018-3522-y","article-title":"Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma","volume":"81","author":"Shang","year":"2018","journal-title":"Cancer Chemother Pharmacol."},{"key":"2022091213240855700_CIT0038","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fcell.2019.00217","article-title":"Novel function of lncRNA ADAMTS9-AS2 in promoting temozolomide resistance in glioblastoma via upregulating the FUS\/MDM2 ubiquitination axis","volume":"7","author":"Yan","year":"2019","journal-title":"Front Cell Dev Biol."},{"issue":"2","key":"2022091213240855700_CIT0039","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1207080","article-title":"Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas\/CD95\/Apo-1","volume":"23","author":"Roos","year":"2004","journal-title":"Oncogene."},{"issue":"5","key":"2022091213240855700_CIT0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/neuonc\/nor011","article-title":"N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide","volume":"13","author":"Tang","year":"2011","journal-title":"Neuro Oncol."},{"issue":"5","key":"2022091213240855700_CIT0041","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neo.2018.02.010","article-title":"Targeting long noncoding RNA HMMR-AS1 suppresses and radiosensitizes glioblastoma","volume":"20","author":"Li","year":"2018","journal-title":"Neoplasia"},{"issue":"6","key":"2022091213240855700_CIT0042","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/ijc.23219","article-title":"MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome","volume":"122","author":"Wiewrodt","year":"2008","journal-title":"Int J Cancer."},{"issue":"9","key":"2022091213240855700_CIT0043","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1078-0432.CCR-14-2737","article-title":"MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial","volume":"21","author":"Weller","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"28","key":"2022091213240855700_CIT0044","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1200\/JCO.2005.06.502","article-title":"Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma","volume":"23","author":"Quinn","year":"2005","journal-title":"J Clin Oncol."},{"issue":"12","key":"2022091213240855700_CIT0045","doi-asserted-by":"crossref","first-page":"19784","DOI":"10.1002\/jcb.29284","article-title":"Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1\/miR-31\/CDK1 pathway","volume":"120","author":"Wang","year":"2019","journal-title":"J Cell Biochem."},{"issue":"14","key":"2022091213240855700_CIT0046","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/1078-0432.CCR-08-3012","article-title":"MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance","volume":"15","author":"Yip","year":"2009","journal-title":"Clin Cancer Res."},{"issue":"4","key":"2022091213240855700_CIT0047","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12094-017-1743-x","article-title":"Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine","volume":"20","author":"Stritzelberger","year":"2018","journal-title":"Clin Transl Oncol."},{"issue":"2","key":"2022091213240855700_CIT0048","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.bjc.6604856","article-title":"Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53","volume":"100","author":"Naumann","year":"2009","journal-title":"Br J Cancer."},{"issue":"10","key":"2022091213240855700_CIT0049","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/1541-7786.MCR-16-0125","article-title":"Augmented HR repair mediates acquired temozolomide resistance in glioblastoma","volume":"14","author":"Gil Del Alcazar","year":"2016","journal-title":"Mol Cancer Res."},{"key":"2022091213240855700_CIT0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cca.2018.01.005","article-title":"Prognostic and clinicopathological value of long noncoding RNA XIST in cancer","volume":"479","author":"Zhu","year":"2018","journal-title":"Clin Chim Acta."},{"issue":"19","key":"2022091213240855700_CIT0051","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.7150\/jca.21024","article-title":"Long non-coding RNA XIST promotes glioma tumorigenicity and angiogenesis by acting as a molecular sponge of miR-429","volume":"8","author":"Cheng","year":"2017","journal-title":"J Cancer."},{"issue":"11","key":"2022091213240855700_CIT0052","first-page":"1255","article-title":"Glioblastoma stem cells resistant to temozolomide-induced autophagy","volume":"122","author":"Fu","year":"2009","journal-title":"Chin Med J (Engl)."},{"issue":"7145","key":"2022091213240855700_CIT0053","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature05862","article-title":"Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age","volume":"447","author":"Rossi","year":"2007","journal-title":"Nature"},{"key":"2022091213240855700_CIT0054","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"Liu","year":"2006","journal-title":"Mol Cancer."},{"issue":"1","key":"2022091213240855700_CIT0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ncrna1010069","article-title":"Long non-coding RNAs dysregulation and function in glioblastoma stem cells","volume":"1","author":"Zhang","year":"2015","journal-title":"Noncoding RNA"},{"issue":"19","key":"2022091213240855700_CIT0056","doi-asserted-by":"crossref","first-page":"31785","DOI":"10.18632\/oncotarget.15991","article-title":"The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells","volume":"8","author":"Brodie","year":"2017","journal-title":"Oncotarget."},{"issue":"6","key":"2022091213240855700_CIT0057","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.3892\/mmr.2020.11542","article-title":"lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR-106a-5p-mediated P38 MAPK signaling","volume":"22","author":"Tang","year":"2020","journal-title":"Mol Med Rep."},{"issue":"3","key":"2022091213240855700_CIT0058","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3892\/mmr.2016.5505","article-title":"Differential long non-coding RNA and mRNA expression in differentiated human glioblastoma stem cells","volume":"14","author":"Li","year":"2016","journal-title":"Mol Med Rep."},{"issue":"12","key":"2022091213240855700_CIT0059","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/neuonc\/nos270","article-title":"Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma","volume":"14","author":"Sch\u00e4fer","year":"2012","journal-title":"Neuro Oncol."},{"key":"2022091213240855700_CIT0060","doi-asserted-by":"crossref","first-page":"109725","DOI":"10.1016\/j.biopha.2019.109725","article-title":"SOX2OT, a novel tumor-related long non-coding RNA","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother."},{"key":"2022091213240855700_CIT0061","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fgene.2015.00196","article-title":"Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis","volume":"6","author":"Shahryari","year":"2015","journal-title":"Front Genet."},{"issue":"3","key":"2022091213240855700_CIT0062","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suv\u00e0","year":"2014","journal-title":"Cell."},{"key":"2022091213240855700_CIT0063","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2016.00222","article-title":"Targeting SOX2 as a therapeutic strategy in glioblastoma","volume":"6","author":"Garros-Regulez","year":"2016","journal-title":"Front Oncol."},{"issue":"8","key":"2022091213240855700_CIT0064","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1101\/gad.293027.116","article-title":"Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators","volume":"31","author":"Bulstrode","year":"2017","journal-title":"Genes Dev."},{"key":"2022091213240855700_CIT0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2019.04.023","article-title":"miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt\/\u03b2-catenin signaling via targeting SOX2","volume":"226","author":"Luo","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"2022091213240855700_CIT0066","doi-asserted-by":"crossref","first-page":"13080","DOI":"10.1038\/s41598-017-10001-0","article-title":"The value of lncRNA NEAT1 as a prognostic factor for survival of cancer outcome: a meta-analysis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep."},{"issue":"5","key":"2022091213240855700_CIT0067","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3892\/or.2016.5098","article-title":"Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol Rep."},{"issue":"3","key":"2022091213240855700_CIT0068","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cns.13197","article-title":"Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma","volume":"26","author":"Wang","year":"2020","journal-title":"CNS Neurosci Ther."},{"issue":"5","key":"2022091213240855700_CIT0069","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3892\/ol.2020.12127","article-title":"miR-138-5p suppresses glioblastoma cell viability and leads to cell cycle arrest by targeting cyclin D3","volume":"20","author":"Wu","year":"2020","journal-title":"Oncol Lett."},{"issue":"1","key":"2022091213240855700_CIT0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/oncotarget.22773","article-title":"SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"issue":"9","key":"2022091213240855700_CIT0071","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/JTO.0b013e3181a97e31","article-title":"Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis","volume":"4","author":"Zhan","year":"2009","journal-title":"J Thorac Oncol."},{"issue":"6 Pt 1","key":"2022091213240855700_CIT0072","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1549-8719.2000.tb00138.x","article-title":"Heterogeneous distribution of tumor blood supply affects the response to chemotherapy in patients with head and neck cancer","volume":"7","author":"Galmarini","year":"2000","journal-title":"Microcirculation."},{"issue":"3","key":"2022091213240855700_CIT0073","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/path.2908","article-title":"The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K\/AKT signalling","volume":"224","author":"Ping","year":"2011","journal-title":"J Pathol."},{"issue":"6","key":"2022091213240855700_CIT0074","first-page":"6781","article-title":"LncRNA AWPPH promotes the invasion and migration of glioma cells through the upregulation of HIF1\u03b1","volume":"18","author":"Zhang","year":"2019","journal-title":"Oncol Lett."},{"issue":"1","key":"2022091213240855700_CIT0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis","volume":"359","author":"Joseph","year":"2015","journal-title":"Cancer Lett."},{"issue":"23","key":"2022091213240855700_CIT0076","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1158\/0008-5472.CAN-07-2253","article-title":"Epithelial-mesenchymal transition events during human embryonic stem cell differentiation","volume":"67","author":"Eastham","year":"2007","journal-title":"Cancer Res."},{"issue":"9","key":"2022091213240855700_CIT0077","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/15384047.2020.1794239","article-title":"Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review","volume":"21","author":"O\u2019Brien","year":"2020","journal-title":"Cancer Biol Ther."},{"issue":"8","key":"2022091213240855700_CIT0078","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/ijms20081924","article-title":"Long noncoding RNA and epithelial mesenchymal transition in cancer","volume":"20","author":"Gugnoni","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"10","key":"2022091213240855700_CIT0079","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/0008-5472.CAN-18-2170","article-title":"Temozolomide treatment induces lncRNA MALAT1 in an NF-\u03baB and p53 codependent manner in glioblastoma","volume":"79","author":"Voce","year":"2019","journal-title":"Cancer Res."},{"issue":"8","key":"2022091213240855700_CIT0080","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/emmm.201302827","article-title":"The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance","volume":"5","author":"Siebzehnrubl","year":"2013","journal-title":"EMBO Mol Med."},{"issue":"6","key":"2022091213240855700_CIT0081","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.febslet.2015.02.005","article-title":"miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8","volume":"589","author":"Yan","year":"2015","journal-title":"FEBS Lett."},{"issue":"1","key":"2022091213240855700_CIT0082","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000494002","article-title":"H19 functions as a competing endogenous RNA to regulate EMT by sponging miR-130a-3p in glioma","volume":"50","author":"Hu","year":"2018","journal-title":"Cell Physiol Biochem."},{"issue":"9","key":"2022091213240855700_CIT0083","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/cells7090125","article-title":"NF-\u03baB, mesenchymal differentiation and glioblastoma","volume":"7","author":"Yamini","year":"2018","journal-title":"Cells"},{"issue":"3215","key":"2022091213240855700_CIT0084","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"2","key":"2022091213240855700_CIT0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J Exp Med."},{"issue":"10","key":"2022091213240855700_CIT0086","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.18632\/oncotarget.3229","article-title":"HOTAIR is a therapeutic target in glioblastoma","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"2022091213240855700_CIT0087","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.apsb.2020.10.001","article-title":"Long non-coding RNAs: from disease code to drug role","volume":"11","author":"Chen","year":"2021","journal-title":"Acta Pharm Sin B."},{"issue":"2","key":"2022091213240855700_CIT0088","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nsmb886","article-title":"Specific and potent RNAi in the nucleus of human cells","volume":"12","author":"Robb","year":"2005","journal-title":"Nat Struct Mol Biol."},{"issue":"1","key":"2022091213240855700_CIT0089","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-5521(94)90039-6","article-title":"Stabilizing effects of the RNA 2\u2032-substituent: crystal structure of an oligodeoxynucleotide duplex containing 2\u2032-O-methylated adenosines","volume":"1","author":"Lubini","year":"1994","journal-title":"Chem Biol."},{"issue":"1","key":"2022091213240855700_CIT0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"issue":"14","key":"2022091213240855700_CIT0091","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1073\/pnas.85.14.5011","article-title":"Role of RNase H in hybrid-arrested translation by antisense oligonucleotides","volume":"85","author":"Walder","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"2022091213240855700_CIT0092","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"2022091213240855700_CIT0093","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/nar\/gkv1210","article-title":"Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts","volume":"44","author":"Burel","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"2022091213240855700_CIT0094","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/cmdc.201000156","article-title":"Off-target effects related to the phosphorothioate modification of nucleic acids","volume":"5","author":"Winkler","year":"2010","journal-title":"ChemMedChem."},{"issue":"R02","key":"2022091213240855700_CIT0095","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1093\/hmg\/ddx215","article-title":"Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape","volume":"26","author":"Wood","year":"2017","journal-title":"Hum Mol Genet."},{"key":"2022091213240855700_CIT0096","doi-asserted-by":"crossref","first-page":"19675","DOI":"10.1038\/srep19675","article-title":"Sequence features associated with the cleavage efficiency of CRISPR\/Cas9 system","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep."},{"key":"2022091213240855700_CIT0097","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nbt.4283","article-title":"Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol."},{"issue":"3","key":"2022091213240855700_CIT0098","first-page":"e12","article-title":"Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes","volume":"45","author":"Goyal","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdac119\/45322010\/vdac119.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/4\/1\/vdac119\/45800165\/vdac119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/4\/1\/vdac119\/45800165\/vdac119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:04:01Z","timestamp":1676361841000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdac119\/6660707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdac119","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]},"article-number":"vdac119"}}